Wegovy

Warnings and Precautions

Wegovy should only be used under the supervision of a healthcare professional. It is not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Do not use Wegovy during pregnancy or breastfeeding.

Common side effects include nausea, vomiting, diarrhoea, constipation, and abdominal pain. Speak with your healthcare provider before starting treatment to confirm Wegovy is appropriate for your health needs.

How to Use Wegovy

1. Consult Your Healthcare Provider:
Ensure Wegovy is right for you and obtain a prescription.

2. Preparation:
Store Wegovy in the refrigerator. Allow the pen to reach room temperature before use.

3. Administration:
Inject Wegovy once weekly using the pre‑filled pen. Suitable injection sites include the abdomen, thigh, or upper arm. Rotate injection sites each week.

4. Follow Instructions:
Follow the instructions provided with the pen for accurate dosing.

5. Missed Dose:
If you miss a dose, take it as soon as possible within 5 days. After 5 days, skip the dose and resume your schedule.

6. Storage:
Store unused pens in the refrigerator. Once in use, pens can be kept at room temperature for up to 4 weeks.

Active Ingredient

Semaglutide: A GLP‑1 receptor agonist used for weight management in adults with obesity or overweight conditions.

Inactive Ingredients

• Disodium Phosphate Dihydrate: A buffering agent that helps maintain the stability and pH of the solution.
• Sodium Chloride: Helps maintain the appropriate salt balance in the solution.
• Hydrochloric Acid (for pH adjustment): Used to adjust the acidity of the solution.
• Sodium Hydroxide (for pH adjustment): Used to balance the pH of the solution.
• Water for Injection: Sterile water used as a solvent for dissolving the active and inactive ingredients.

These ingredients combine to form a stable and effective injectable solution for weight management. Always refer to the medication guide for the most detailed and up‑to‑date information.

Common Side Effects of Wegovy

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain

Less Common Side Effects

• Indigestion
• Fatigue
• Dizziness
• Bloating
• Belching
• Gas

Serious Side Effects

• Severe allergic reactions (rash, swelling, severe dizziness, difficulty breathing)
• Pancreatitis (severe stomach or abdominal pain, persistent vomiting)
• Gallbladder problems (gallstones, cholecystitis, yellowing of the eyes or skin)
• Kidney problems (changes in urine output)
• Increased heart rate

Note: This is not a complete list of possible side effects. If you experience any unusual symptoms or reactions, contact your healthcare provider immediately. Always seek professional medical advice for guidance specific to your health needs.

Frequently Asked Questions

1. What is Wegovy (Semaglutide)?
Wegovy is a GLP‑1 medication used to help adults with obesity or overweight conditions regulate appetite and achieve weight loss.

2. How is Wegovy administered?
Wegovy is injected once weekly using a pre‑filled pen. Injections can be given in the abdomen, thigh, or upper arm.

3. What are the common side effects of Wegovy?
Common side effects include nausea, vomiting, diarrhoea, constipation, and abdominal pain. These usually lessen over time.

4. Who should not use Wegovy?
Wegovy is not suitable for individuals with a personal or family history of medullary thyroid carcinoma or MEN2. It should not be used during pregnancy or breastfeeding.

5. How soon can I expect results?
Many users notice appetite reduction within a few weeks. Weight loss increases as doses escalate and healthy lifestyle measures continue.